{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:45:43Z","timestamp":1776311143796,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004481","name":"University of Tehran","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100004481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12223-019-00768-2","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T11:02:43Z","timestamp":1578308563000},"page":"639-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Bioprospecting of indigenous myxobacteria from Iran and potential of Cystobacter as a source of anti-MDR compounds"],"prefix":"10.1007","volume":"65","author":[{"given":"Fatemeh","family":"Saadatpour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0286-5342","authenticated-orcid":false,"given":"Fatemeh","family":"Mohammadipanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"768_CR1","doi-asserted-by":"publisher","first-page":"e01601","DOI":"10.1128\/genomeA.01601-16","volume":"5","author":"S Akbar","year":"2017","unstructured":"Akbar S, Dowd SE, Stevens DC (2017) Draft genome sequence of Cystobacter ferrugineus strain Cbfe23. Genome announc 5:e01601\u2013e01616","journal-title":"Genome announc"},{"key":"768_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MMBR.00019-15","volume":"80","author":"EA Barka","year":"2016","unstructured":"Barka EA et al (2016) Taxonomy, physiology, and natural products of Actinobacteria. Microbiol Mol Bio Rev 80:1\u201343","journal-title":"Microbiol Mol Bio Rev"},{"key":"768_CR3","doi-asserted-by":"crossref","unstructured":"Basak S, Singh P, Rajurkar M (2016) Multidrug resistant and extensively drug resistant bacteria. SJP:2016","DOI":"10.1155\/2016\/4065603"},{"key":"768_CR4","doi-asserted-by":"publisher","first-page":"14605","DOI":"10.1002\/anie.201409964","volume":"53","author":"S Baumann","year":"2014","unstructured":"Baumann S et al (2014) Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activity. ACIE 53:14605\u201314609","journal-title":"ACIE"},{"key":"768_CR5","doi-asserted-by":"crossref","unstructured":"Blanco N, O\u2019Hara LM, Harris AD (2019) Transmission pathways of multidrug-resistant organisms in the hospital setting: a scoping review. Infect Control Hosp Epidemiol:1\u201310","DOI":"10.1017\/ice.2018.359"},{"key":"768_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cmrp.2018.01.001","volume":"8","author":"SS Boswihi","year":"2018","unstructured":"Boswihi SS, Udo EE (2018) Methicillin-resistant Staphylococcus aureus: an update on the epidemiology, treatment options and infection control. Current Medicine Research and Practice 8:18\u201324","journal-title":"Current Medicine Research and Practice"},{"key":"768_CR7","doi-asserted-by":"crossref","unstructured":"Brenner DJ, Staley JT, Krieg NR (2015) Classification of procaryotic organisms and the concept of bacterial speciation. Bergey\u2019s Manual of Systematics of Archaea and Bacteria:1\u20139","DOI":"10.1002\/9781118960608.bm00006"},{"key":"768_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12223-017-0502-2","volume":"62","author":"Charousov\u00e1","year":"2017","unstructured":"Charousov\u00e1 et al (2017) Soil myxobacteria as a potential source of polyketide-peptide substances. Folia Microbiol 62:305\u2013315","journal-title":"Folia Microbiol"},{"key":"768_CR9","unstructured":"Freeman-Cook L, Freeman-Cook KD, Alcamo IE (2006) Staphylococcus aureus infections. Infobase publishing"},{"key":"768_CR10","doi-asserted-by":"crossref","unstructured":"Garcia R, M\u00fcller R (2014) The family Myxococcaceae The Prokaryotes: Deltaproteobacteria and Epsilonproteobacteria:191\u2013212","DOI":"10.1007\/978-3-642-39044-9_303"},{"key":"768_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0076-6879(09)04803-4","volume":"458","author":"RO Garcia","year":"2009","unstructured":"Garcia RO, Krug D, M\u00fcller R (2009) Discovering natural products from myxobacteria with emphasis on rare producer strains in combination with improved analytical methods. Meth in enzymol 458:59\u201391","journal-title":"Meth in enzymol"},{"key":"768_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2672.2004.02477.x","volume":"98","author":"F Gaspari","year":"2005","unstructured":"Gaspari F, Paitan Y, Mainini M, Losi D, Ron E, Marinelli F (2005) Myxobacteria isolated in Israel as potential source of new anti-infectives. J App Microbil 98:429\u2013439","journal-title":"J App Microbil"},{"key":"768_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jbiotec.2003.07.015","volume":"106","author":"K Gerth","year":"2003","unstructured":"Gerth K, Pradella S, Perlova O, Beyer S, M\u00fcller R (2003) Myxobacteria: proficient producers of novel natural products with various biological activities\u2014past and future biotechnological aspects with the focus on the genus Sorangium. J Biotech 106:233\u2013253","journal-title":"J Biotech"},{"key":"768_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1039\/C6NP00106H","volume":"34","author":"J Herrmann","year":"2017","unstructured":"Herrmann J, Fayad AA, M\u00fcller R (2017) Natural products from myxobacteria: novel metabolites and bioactivities. Nat Prod Rep 34:135\u2013160","journal-title":"Nat Prod Rep"},{"key":"768_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41467-018-03184-1","volume":"9","author":"T Hoffmann","year":"2018","unstructured":"Hoffmann T et al (2018) Correlating chemical diversity with taxonomic distance for discovery of natural products in myxobacteria. Nat Commun 9:803","journal-title":"Nat Commun"},{"key":"768_CR16","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1021\/np200036v","volume":"74","author":"N Horstmann","year":"2011","unstructured":"Horstmann N, Essig S, Bockelmann S, Wieczorek H, Huss M, Sasse F, Menche D (2011) Archazolid A-15-O-\u03b2-D-glucopyranoside and iso-archazolid B: potent V-ATPase inhibitory polyketides from the myxobacteria Cystobacter violaceus and Archangium gephyra. J Nat Prod 74:1100\u20131105","journal-title":"J Nat Prod"},{"key":"768_CR17","first-page":"175","volume":"54","author":"H Hyun","year":"2018","unstructured":"Hyun H, Cho K (2018) Secondary metabolites of myxobacteria. The Microbiological Society of Korea 54:175\u2013187","journal-title":"The Microbiological Society of Korea"},{"key":"768_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/0974-777X.157245","volume":"7","author":"DC Kaur","year":"2015","unstructured":"Kaur DC, Chate SS (2015) Study of antibiotic resistance pattern in methicillin resistant Staphylococcus aureus with special reference to newer antibiotic. J Glob Infect Diseas 7:78","journal-title":"J Glob Infect Diseas"},{"key":"768_CR19","first-page":"309","volume":"9","author":"R Kaur","year":"2018","unstructured":"Kaur R, Kumari A, Kaur R, Kaur R (2018) Myxobacteria: producers of enormous bioactive secondary metabolites international. Journal of Research in Pharma Science 9:309\u2013313","journal-title":"Journal of Research in Pharma Science"},{"key":"768_CR20","unstructured":"Kersters K, Vancanneyt M (2005) Bergey's manual of systematic bacteriology. Springer Verlag"},{"key":"768_CR21","doi-asserted-by":"publisher","first-page":"10217","DOI":"10.1016\/j.tet.2004.09.013","volume":"60","author":"BA Kundim","year":"2004","unstructured":"Kundim BA, Itou Y, Sakagami Y, Fudou R, Yamanaka S, Ojika M (2004) Novel antifungal polyene amides from the myxobacterium Cystobacter fuscus: isolation, antifungal activity and absolute structure determination. Tetrahedron 60:10217\u201310221","journal-title":"Tetrahedron"},{"key":"768_CR22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.7164\/antibiotics.35.635","volume":"35","author":"B Kunze","year":"1982","unstructured":"Kunze B, Reichenbach H, Augustiniak H, H\u00f6fle G (1982) Isolation and identification of althiomycin from Cystobacter fuscus (Myxobacterales). J Antibiot 35:635\u2013636","journal-title":"J Antibiot"},{"key":"768_CR23","first-page":"486","volume":"5","author":"B Lade","year":"2014","unstructured":"Lade B, Patil A, Paikrao H, Kale A, Hire K (2014) A comprehensive working, principles and applications of thin layer chromatography. Res J Pharm Bio Chem Sci 5:486\u2013503","journal-title":"Res J Pharm Bio Chem Sci"},{"key":"768_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1039\/C7NP00010C","volume":"34","author":"J Masschelein","year":"2017","unstructured":"Masschelein J, Jenner M, Challis G (2017) Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights. Nat Prod Rep 34:712\u2013783","journal-title":"Nat Prod Rep"},{"key":"768_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/microorganisms6030084","volume":"6","author":"K Mohr","year":"2018","unstructured":"Mohr K (2018) Diversity of myxobacteria\u2014we only see the tip of the iceberg. Microorganisms 6:84","journal-title":"Microorganisms"},{"key":"768_CR26","unstructured":"Nadmid S (2015) Isolation and characterization of novel natural compounds from Myxobacteria"},{"key":"768_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00284-004-4406-4","volume":"50","author":"RB Neil","year":"2005","unstructured":"Neil RB, Hite D, Kelrick MI, Lockhart ML, Lee K (2005) Myxobacterial biodiversity in an established oak-hickory forest and a savanna restoration site. Current Microbil 50:88\u201395","journal-title":"Current Microbil"},{"key":"768_CR28","doi-asserted-by":"crossref","unstructured":"Newman DJ (2018) From natural products to drugs. Phy Sci Rev","DOI":"10.1515\/psr-2018-0111"},{"key":"768_CR29","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman DJ, Cragg GM (2016) Natural products as sources of new drugs from 1981 to 2014. J Nat Prod 79:629\u2013661","journal-title":"J Nat Prod"},{"key":"768_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.7164\/antibiotics.51.275","volume":"51","author":"M Ojika","year":"1998","unstructured":"Ojika M, Suzuki Y, Tsukamoto A, Sakagami Y, Fudou R, Yoshimura T, Yamanaka S (1998) Cystothiazoles A and B, new bithiazole-type antibiotics from the myxobacterium Cystobacter fuscus. J Antibiot 51:275\u2013281","journal-title":"J Antibiot"},{"key":"768_CR31","unstructured":"Parte (2019) LPSN, http:\/\/www.bacterio.net\/cystobacter"},{"key":"768_CR32","unstructured":"Patel JB (2017) Performance standards for antimicrobial susceptibility testing. CLSI"},{"key":"768_CR33","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1056\/NEJMe1506276","volume":"372","author":"EG Phimister","year":"2015","unstructured":"Phimister EG, Arias CA, Murray BE (2015) A new antibiotic and the evolution of resistance. NEJM 372:1168\u20131170","journal-title":"NEJM"},{"key":"768_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/ja.2015.8","volume":"68","author":"R Raju","year":"2015","unstructured":"Raju R, Mohr KI, Bernecker S, Herrmann J, M\u00fcller R (2015) Cystodienoic acid: a new diterpene isolated from the myxobacterium Cystobacter sp. J Antibiot 68:473","journal-title":"J Antibiot"},{"key":"768_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/j.1462-2920.1999.00016.x","volume":"1","author":"H Reichenbach","year":"1999","unstructured":"Reichenbach H (1999) The ecology of the myxobacteria. Env Microbial 1:15\u201321","journal-title":"Env Microbial"},{"key":"768_CR36","doi-asserted-by":"crossref","unstructured":"Sasse F, Leibold T, Kunze B , H\u00f6fle G, Reinchenbach H (2003) Cyrmenins, new \u03b2-methoxyacrylate inhibitors of the electron transport production, isolation, physico-chemical and biological properties. J Antibiot 56(10):827\u2013831","DOI":"10.7164\/antibiotics.56.827"},{"key":"768_CR37","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.3390\/md8092466","volume":"8","author":"TF Sch\u00e4berle","year":"2010","unstructured":"Sch\u00e4berle TF, Goralski E, Neu E, Erol O, H\u00f6lzl G, D\u00f6rmann P, Bierbaum G, K\u00f6nig GM (2010) Marine myxobacteria as a source of antibiotics\u2014comparison of physiology, polyketide-type genes and antibiotic production of three new isolates of Enhygromyxa salina. Mar drugs 8:2466\u20132479","journal-title":"Mar drugs"},{"key":"768_CR38","doi-asserted-by":"crossref","unstructured":"Sch\u00e4berle TF, Lohr F, Schmitz A, K\u00f6nig GM (2014) Antibiotics from myxobacteria. Nat Prod Rep","DOI":"10.1039\/c4np00011k"},{"key":"768_CR39","first-page":"31","volume-title":"The myxobacteria","author":"LJ Shimkets","year":"2006","unstructured":"Shimkets LJ, Dworkin M, Reichenbach H (2006) The myxobacteria. The prokaryotes. Springer, In, pp 31\u2013115"},{"key":"768_CR40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/s-2006-959661","volume":"59","author":"PN Solis","year":"1993","unstructured":"Solis PN, Wright CW, Anderson MM, Gupta MP, Phillipson JD (1993) A microwell cytotoxicity assay using Artemia salina (brine shrimp). Planta Med 59:250\u2013252","journal-title":"Planta Med"},{"key":"768_CR41","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.bmc.2008.11.025","volume":"17","author":"KJ Weissman","year":"2009","unstructured":"Weissman KJ, M\u00fcller R (2009) A brief tour of myxobacterial secondary metabolism. Bioorg Med Chem 17:2121\u20132136","journal-title":"Bioorg Med Chem"},{"key":"768_CR42","unstructured":"White D (1993) Myxospore and fruiting body morphogenesis Myxobacteria II. ASM DC:307-332"},{"key":"768_CR43","doi-asserted-by":"crossref","unstructured":"Whitman WB (2015) Bergey's manual of systematics of archaea and bacteria vol 410. Wiley Online Library,","DOI":"10.1002\/9781118960608"},{"key":"768_CR44","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1128\/JB.129.2.798-802.1977","volume":"129","author":"JW Wireman","year":"1977","unstructured":"Wireman JW, Dworkin M (1977) Developmentally induced autolysis during fruiting body formation by Myxococcus xanthus. J Bacteral 129:798\u2013802","journal-title":"J Bacteral"},{"key":"768_CR45","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0960-9822(02)00716-9","volume":"12","author":"C Wolgemuth","year":"2002","unstructured":"Wolgemuth C, Hoiczyk E, Kaiser D, Oster G (2002) How myxobacteria glide. Current Bio 12:369\u2013377","journal-title":"Current Bio"},{"key":"768_CR46","unstructured":"World Health Organization (2014) Antimicrobial resistance: global report on surveillance"},{"key":"768_CR47","unstructured":"Zander W (2011) Isolation, characterisation and biosynthetic precursors of natural products from myxobacteria"},{"key":"768_CR48","doi-asserted-by":"publisher","first-page":"e70466","DOI":"10.1371\/journal.pone.0070466","volume":"8","author":"X Zhang","year":"2013","unstructured":"Zhang X, Yao Q, Cai Z, Xie X, Zhu H (2013) Isolation and identification of Myxobacteria from saline-alkaline soils in Xinjiang, China. PLoS One 8:e70466","journal-title":"PLoS One"},{"key":"768_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/1758-2229.12107","volume":"6","author":"XW Zhou","year":"2014","unstructured":"Zhou XW, Li S, Li W, Dm J, Han K, Wu Z, Yz L (2014) Myxobacterial community is a predominant and highly diverse bacterial group in soil niches. Environ Microbiol Rep 6:45\u201356","journal-title":"Environ Microbiol Rep"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-019-00768-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12223-019-00768-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-019-00768-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T19:35:23Z","timestamp":1695584123000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12223-019-00768-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1007\/s12223-019-00768-2","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"18 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}